Rhonda Patrick· PhD
Intravenous vitamin C given to patients with lung cancer nearly doubled the shrinking of their tumors after chemo.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Intravenous vitamin C given to patients with lung cancer nearly doubled the shrinking of their tumors after chemo.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
many clinical studies have since suggested a beneficial use for intravenous vitamin C as adjunct of therapy for cancer with many of the findings suggesting a trend in overall survival rate for patients administered intravenously diamond C in conjunction with the standard therapy
Pauling was a Nobel Prize winning chemist who found clinical evidence suggesting that high-dose intravenous administration of vitamin C is useful as a supportive treatment for cancer as well as a method to reduce the side effects of chemotherapy